sr141716 has been researched along with physostigmine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Lichtman, AH; Martin, BR | 1 |
| Braida, D; Sala, M | 1 |
| Bura, SA; Castañé, A; Ledent, C; Maldonado, R; Valverde, O | 1 |
4 other study(ies) available for sr141716 and physostigmine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism.
Topics: Animals; Dronabinol; Male; Maze Learning; Memory; Physostigmine; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Scopolamine | 1996 |
Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats.
Topics: Animals; Behavior, Animal; Cannabinoids; Cholinesterase Inhibitors; Cyclohexanols; Male; Maze Learning; Memory; Memory Disorders; Motor Activity; Physostigmine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rimonabant | 2000 |
Genetic and pharmacological approaches to evaluate the interaction between the cannabinoid and cholinergic systems in cognitive processes.
Topics: Animals; Avoidance Learning; Cognition; Male; Mice; Mice, Knockout; Nicotine; Physostigmine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Nicotinic; Rimonabant; Scopolamine | 2007 |